Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis caused by poor surface tension. Curosurf (portactant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.
Related Animations
